{"id":"https://openalex.org/W4414570331","doi":"https://doi.org/10.52711/0974-360x.2025.00629","title":"Exploring the Binding Affinities of 2-Methyl-N-(1,3-Dioxoisoindolin-2-yl) Benzamide Derivatives as Potent DPP-4 Inhibitors\"","display_name":"Exploring the Binding Affinities of 2-Methyl-N-(1,3-Dioxoisoindolin-2-yl) Benzamide Derivatives as Potent DPP-4 Inhibitors\"","alternate_titles":[],"publication_year":2025,"publication_date":"2025-09-05","ids":{"openalex":"https://openalex.org/W4414570331","doi":"https://doi.org/10.52711/0974-360x.2025.00629"},"language":"en","primary_location":{"id":"doi:10.52711/0974-360x.2025.00629","doi":"https://doi.org/10.52711/0974-360x.2025.00629","is_oa":false,"landing_page_url":"https://doi.org/10.52711/0974-360x.2025.00629","pdf_url":null,"source":{"id":"https://openalex.org/S4210228335","display_name":"Research Journal of Pharmacy and Technology","issn_l":"0974-360X","issn":["0974-360X","0974-3618"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research Journal of Pharmacy and Technology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4414570331"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011919168","display_name":"Parul Singh","orcid":"https://orcid.org/0000-0002-4039-5102","observed_orcids":["https://orcid.org/0000-0002-4039-5102"]},"institutions":[{"id":"https://openalex.org/I4405287327","display_name":"Pranveer Singh Institute of Technology (Pharmacy), Kanpur","ror":"https://ror.org/04v8v3741","country_code":"IN","type":"education","lineage":["https://openalex.org/I4405287327"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Parul Singh","raw_affiliation_strings":["PSIT- Pranveer Singh Institute of Technology, (Pharmacy), Kanpur - 209305, Uttar Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PSIT- Pranveer Singh Institute of Technology, (Pharmacy), Kanpur - 209305, Uttar Pradesh, India","institution_ids":["https://openalex.org/I4405287327"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Nidhi Srivastava","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nidhi Srivastava","raw_affiliation_strings":["School of Pharmaceutical Sciences, Maharishi University of Information Technology, Lucknow,  Uttar Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmaceutical Sciences, Maharishi University of Information Technology, Lucknow,  Uttar Pradesh, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086955205","display_name":"Akash Ved","orcid":"https://orcid.org/0000-0001-8487-3885","observed_orcids":["https://orcid.org/0000-0001-8487-3885"]},"institutions":[{"id":"https://openalex.org/I116943215","display_name":"Dr. A.P.J. Abdul Kalam Technical University","ror":"https://ror.org/03h56sg55","country_code":"IN","type":"education","lineage":["https://openalex.org/I116943215"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Akash Ved","raw_affiliation_strings":["Dr. A. P. J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. A. P. J. Abdul Kalam Technical University, Lucknow, Uttar Pradesh, India","institution_ids":["https://openalex.org/I116943215"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4915,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.52436772,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":null,"issue":null,"first_page":"4389","last_page":"4395"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.11999999731779099,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.04490000009536743,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9829999804496765},{"id":"https://openalex.org/keywords/dipeptidyl-peptidase-4","display_name":"dipeptidyl peptidase IV","score":0.8849999904632568},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8640000224113464},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.6880000233650208},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.9020000100135803},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8809999823570251}],"concepts":[{"id":"https://openalex.org/C2780231548","wikidata":"https://www.wikidata.org/wiki/Q417731","display_name":"Benzamide","level":2,"score":0.8051999807357788},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.7971000075340271},{"id":"https://openalex.org/C3018795828","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Binding affinities","level":3,"score":0.6085000038146973},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.548799991607666},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5011000037193298},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.47540000081062317},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4745999872684479},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4683000147342682},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.40380001068115234},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.39570000767707825},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.39500001072883606},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.3743000030517578},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.3549000024795532},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3490999937057495},{"id":"https://openalex.org/C3020299119","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Binding pocket","level":3,"score":0.3474999964237213},{"id":"https://openalex.org/C2780283098","wikidata":"https://www.wikidata.org/wiki/Q4688960","display_name":"Affinities","level":2,"score":0.3334999978542328},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.31450000405311584},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.3091999888420105},{"id":"https://openalex.org/C169627665","wikidata":"https://www.wikidata.org/wiki/Q5767913","display_name":"Homology modeling","level":3,"score":0.3073999881744385},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.3041999936103821},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2973000109195709},{"id":"https://openalex.org/C77319485","wikidata":"https://www.wikidata.org/wiki/Q7251520","display_name":"Protein\u2013ligand docking","level":4,"score":0.2890999913215637},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2815999984741211},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.27900001406669617},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.2761000096797943},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.2728999853134155},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.27079999446868896},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2639000117778778},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.25679999589920044},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.2513999938964844},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.2508000135421753}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.52711/0974-360x.2025.00629","doi":"https://doi.org/10.52711/0974-360x.2025.00629","is_oa":false,"landing_page_url":"https://doi.org/10.52711/0974-360x.2025.00629","pdf_url":null,"source":{"id":"https://openalex.org/S4210228335","display_name":"Research Journal of Pharmacy and Technology","issn_l":"0974-360X","issn":["0974-360X","0974-3618"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Research Journal of Pharmacy and Technology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1596856477","https://openalex.org/W2005007925","https://openalex.org/W2008427683","https://openalex.org/W2134967712","https://openalex.org/W2155198744","https://openalex.org/W2255694181","https://openalex.org/W2260574475","https://openalex.org/W2283157976","https://openalex.org/W2330278064","https://openalex.org/W2509754533","https://openalex.org/W2513068147","https://openalex.org/W2885551836","https://openalex.org/W2896393803","https://openalex.org/W2912503189","https://openalex.org/W2983176168","https://openalex.org/W3012514664","https://openalex.org/W3033000700","https://openalex.org/W3034047874","https://openalex.org/W3042565727","https://openalex.org/W3045987801","https://openalex.org/W3092005301","https://openalex.org/W3111685510","https://openalex.org/W3127553579","https://openalex.org/W3128704918","https://openalex.org/W3129188118","https://openalex.org/W3183794444","https://openalex.org/W4312185953","https://openalex.org/W4391315317","https://openalex.org/W6991678112"],"related_works":["https://openalex.org/W4393113534","https://openalex.org/W4411453684","https://openalex.org/W7162758341","https://openalex.org/W4410788218","https://openalex.org/W7223330170","https://openalex.org/W4415224436","https://openalex.org/W2425046597","https://openalex.org/W3168749549","https://openalex.org/W7166696245","https://openalex.org/W7160617242"],"abstract_inverted_index":{"Diabetes":[0],"mellitus,":[1],"particularly":[2],"type":[3],"2":[4],"diabetes,":[5],"remains":[6],"a":[7,49,87,125],"critical":[8],"global":[9],"health":[10],"challenge":[11],"necessitating":[12],"novel":[13],"therapeutic":[14],"approaches.":[15],"Dipeptidyl":[16],"peptidase-4":[17],"(DPP-4)":[18],"inhibitors":[19],"have":[20],"emerged":[21],"as":[22,100,118],"promising":[23],"agents":[24],"in":[25,129,132],"diabetes":[26],"management":[27],"by":[28],"enhancing":[29],"glucose":[30],"regulation":[31],"through":[32],"incretin":[33],"hormone":[34],"stabilization.":[35],"This":[36],"study":[37],"investigates":[38],"the":[39,71,75,83,105,142],"molecular":[40],"docking":[41,56,63,72,88],"interactions":[42,95],"between":[43],"DPP-4":[44,120],"(PDB":[45],"ID:":[46],"2OQV)":[47],"and":[48,70,113,131,137],"series":[50],"of":[51,74,90,109,144],"2-methyl-N-(1,3-dioxoisoindolin-2-yl)":[52],"benzamide":[53],"derivatives.":[54],"Our":[55],"simulations":[57],"revealed":[58],"significant":[59],"binding":[60,107],"affinities,":[61],"with":[62,86,96],"scores":[64],"ranging":[65],"from":[66],"-8.0":[67],"to":[68,135],"-9.0":[69],"score":[73,89],"Co-crystallize":[76],"ligand":[77],"is":[78],"-10.1.":[79],"Compound":[80],"P-2":[81],"exhibited":[82],"highest":[84],"affinity":[85],"-9.0,":[91],"demonstrating":[92],"multiple":[93],"stable":[94],"key":[97],"residues":[98],"such":[99],"Tyr662.":[101],"Comparative":[102],"analysis":[103],"highlighted":[104],"robust":[106],"profiles":[108],"compounds":[110],"P-1,":[111],"P-3,":[112],"P-4,":[114],"underscoring":[115],"their":[116],"potential":[117],"effective":[119],"inhibitors.":[121],"These":[122],"findings":[123],"provide":[124],"foundation":[126],"for":[127],"further":[128],"vitro":[130],"vivo":[133],"studies":[134],"validate":[136],"optimize":[138],"these":[139],"compounds,":[140],"advancing":[141],"development":[143],"next-generation":[145],"antidiabetic":[146],"agents.":[147]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4414570331","counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-10-10T00:00:00"}
